0001179110-20-005301.txt : 20200430
0001179110-20-005301.hdr.sgml : 20200430
20200430185701
ACCESSION NUMBER: 0001179110-20-005301
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200428
FILED AS OF DATE: 20200430
DATE AS OF CHANGE: 20200430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MITCHELL DEAN J
CENTRAL INDEX KEY: 0001199297
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 20837678
MAIL ADDRESS:
STREET 1: C/O BRISTOL MYERS SQUIBB CO
STREET 2: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10164
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
4
1
edgar.xml
FORM 4 -
X0306
4
2020-04-28
0
0001583107
Theravance Biopharma, Inc.
TBPH
0001199297
MITCHELL DEAN J
C/O THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BLVD
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Ordinary Shares
2020-04-28
4
A
0
6635
0
A
41206
D
Share Option (Right to Buy)
30.14
2020-04-28
4
A
0
6000
0
A
2030-04-27
Ordinary Shares
6000
6000
D
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date.
Brett A. Grimaud, Attorney-in-Fact
2020-04-30